Trial intelligence / Profile preview

DHEA for Endothelial Dysfunction in Premenopausal Women With Systemic Lupus

NCT00189124Phase 3Completed

Sponsor
University of Michigan
Start
Sep 2003
Primary completion
Dec 2005
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 3 trial of dehydroepiandrosterone in systemic lupus erythematosus (SLE), sponsored by University of Michigan. Started Sep 2003; status: completed.

02

Drugs

dehydroepiandrosterone
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on NCT00189124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00189124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call